184 related articles for article (PubMed ID: 16386634)
1. Invasive pulmonary aspergillosis in solid organ and bone marrow transplant recipients.
Trullas JC; Cervera C; Benito N; de la Bellacasa JP; Agustí C; Rovira M; Mas A; Navasa M; Cofan F; Ricart MJ; Pérez-Villa F; Moreno A
Transplant Proc; 2005 Nov; 37(9):4091-3. PubMed ID: 16386634
[TBL] [Abstract][Full Text] [Related]
2. Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B.
Linden PK; Coley K; Fontes P; Fung JJ; Kusne S
Clin Infect Dis; 2003 Jul; 37(1):17-25. PubMed ID: 12830404
[TBL] [Abstract][Full Text] [Related]
3. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E
Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary aspergillosis in solid organ transplant patients: a report from Iran.
Marjani M; Tabarsi P; Najafizadeh K; Rashid Farokhi F; Sharifkashani B; Motahari S; Abbasi A; Masjedi MR; Mansouri D
Transplant Proc; 2008 Dec; 40(10):3663-7. PubMed ID: 19100461
[TBL] [Abstract][Full Text] [Related]
5. Invasive pulmonary aspergillosis following bone marrow transplantation: risk factors and diagnostic aspect.
Soubani AO; Qureshi MA
Haematologia (Budap); 2002; 32(4):427-37. PubMed ID: 12803117
[TBL] [Abstract][Full Text] [Related]
6. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
Hachem RY; Boktour MR; Hanna HA; Husni RN; Torres HA; Afif C; Kontoyiannis DP; Raad II
Cancer; 2008 Mar; 112(6):1282-7. PubMed ID: 18224662
[TBL] [Abstract][Full Text] [Related]
7. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of high doses of liposomal amphotericin B in the treatment of experimental aspergillosis.
Martín MT; Gavaldà J; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Jordano Q; Ruiz I; Rosal M; Almirante B; Pahissa A
J Antimicrob Chemother; 2003 Dec; 52(6):1032-4. PubMed ID: 14613950
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients.
Jantunen E; Piilonen A; Volin L; Parkkali T; Koukila-Kähkölä P; Ruutu T; Ruutu P
Bone Marrow Transplant; 2000 Apr; 25(8):867-71. PubMed ID: 10808208
[TBL] [Abstract][Full Text] [Related]
10. Secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipients.
Allinson K; Kolve H; Gumbinger HG; Vormoor HJ; Ehlert K; Groll AH
J Antimicrob Chemother; 2008 Mar; 61(3):734-42. PubMed ID: 18238891
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
12. Inhaled amphotericin B for prophylaxis against invasive Aspergillus infections.
Mohammad RA; Klein KC
Ann Pharmacother; 2006 Dec; 40(12):2148-54. PubMed ID: 17148653
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model.
Nagasaki Y; Eriguchi Y; Uchida Y; Miyake N; Maehara Y; Kadowaki M; Harada M; Akashi K; Shimono N
J Antimicrob Chemother; 2009 Aug; 64(2):379-82. PubMed ID: 19465436
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation.
Ringdén O; Andström EE; Remberger M; Dahllöf G; Svahn BM; Tollemar J
Pediatr Transplant; 1997 Nov; 1(2):124-9. PubMed ID: 10084772
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of sequential Aspergillus galactomannan antigen detection combined with early radiologic evaluation for diagnosis of invasive pulmonary aspergillosis in patients undergoing allogeneic stem cell transplantation.
Busca A; Locatelli F; Barbui A; Limerutti G; Serra R; Libertucci D; Falda M
Transplant Proc; 2006 Jun; 38(5):1610-3. PubMed ID: 16797366
[TBL] [Abstract][Full Text] [Related]
16. Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients.
Jantunen E; Ruutu P; Piilonen A; Volin L; Parkkali T; Ruutu T
Bone Marrow Transplant; 2000 Oct; 26(7):759-62. PubMed ID: 11042657
[TBL] [Abstract][Full Text] [Related]
17. The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis.
Muñoz P; Alcalá L; Sánchez Conde M; Palomo J; Yáñez J; Pelaez T; Bouza E
Transplantation; 2003 Feb; 75(3):326-9. PubMed ID: 12589152
[TBL] [Abstract][Full Text] [Related]
18. Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.
Grow WB; Moreb JS; Roque D; Manion K; Leather H; Reddy V; Khan SA; Finiewicz KJ; Nguyen H; Clancy CJ; Mehta PS; Wingard JR
Bone Marrow Transplant; 2002 Jan; 29(1):15-9. PubMed ID: 11840139
[TBL] [Abstract][Full Text] [Related]
19. Invasive zygomycosis in transplant recipients.
Uçkay I; Chalandon Y; Sartoretti P; Rohner P; Berney T; Hadaya K; van Delden C
Clin Transplant; 2007; 21(4):577-82. PubMed ID: 17645724
[TBL] [Abstract][Full Text] [Related]
20. Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B.
Kontoyiannis DP; Andersson BS; Lewis RE; Raad II
Clin Infect Dis; 2001 Mar; 32(5):E94-6. PubMed ID: 11229866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
